- Report
- August 2022
- 327 Pages
Global
From €3481EUR$3,600USD£2,984GBP
- Report
- January 2022
- 275 Pages
Global
From €3481EUR$3,600USD£2,984GBP
- Report
- November 2021
- 545 Pages
Global
From €3868EUR$4,000USD£3,315GBP
- Report
- March 2023
- 280 Pages
Global
From €5541EUR$5,730USD£4,749GBP
- Report
- March 2023
- 420 Pages
Global
From €5628EUR$5,820USD£4,824GBP
- Report
- February 2023
- 427 Pages
Global
From €5541EUR$5,730USD£4,749GBP
- Report
- February 2024
- 140 Pages
Global
From €5318EUR$5,499USD£4,558GBP
- Book
- January 2022
- 336 Pages
- Book
- March 2019
- 348 Pages
- Book
- January 2012
- 660 Pages
- Book
- November 2013
- 400 Pages
High Throughput Sequencing (HTS) is a biotechnology technique used to rapidly sequence large amounts of DNA or RNA. It is used to identify genetic variations, detect mutations, and analyze gene expression. HTS is used in a variety of applications, including drug discovery, diagnostics, and personalized medicine. It is also used in research to study the genetic basis of diseases, to identify biomarkers, and to understand the evolution of species.
HTS has revolutionized the biotechnology industry, allowing researchers to quickly and accurately sequence large amounts of genetic material. This has enabled the development of new treatments and diagnostics, as well as the identification of new biomarkers.
Companies in the HTS market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more